Position in TSHA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$66,010,991
+$26,407,189 QoQ
Shares Held
9,693,244
+9.4% QoQ
Ownership
2.97%
of shares outstanding
% of Portfolio
6.06%
of 13F equity value
Holder Rank
#12
of 208 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Octagon Capital Advisors LP holds $1,046,707,283 across 25 Biotechnology names. TSHA ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,841,667 | $179,525,699 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
2,950,000 | $138,768,000 | |
| 3 | ABVX |
Abivax S.A.
|
993,000 | $132,327,180 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
2,350,000 | $90,945,000 | |
| 5 | ALMS |
Alumis Inc.
|
2,830,700 | $79,655,898 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,971,054 | $68,474,415 | |
| 7 | TSHA |
Taysha Gene Therapies, Inc.
This page
|
9,693,244 | $66,010,991 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
338,900 | $39,675,023 |
All Filings in TSHA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,010,991 | 9,693,244 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,603,802 | 8,859,911 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $48,729,510 | 8,859,911 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,650,725 | 9,067,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,088,675 | 12,592,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,873,000 | 10,700,000 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $18,078,500 | 10,450,000 | Shares | Sole | 2025-02-05 | |
| 2024-12-31 | $18,078,500 | 10,450,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,190,166 | 4,572,222 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,241,777 | 4,572,222 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,696,100 | 3,030,000 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $8,777,778 | 2,777,778 | Shares | Sole | 2023-11-14 | |
| 2021-06-30 | $6,793,328 | 320,440 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,504,932 | 320,440 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,504,477 | 320,440 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||